UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000050722
Receipt number R000057778
Scientific Title A study of the relationship between energy metabolism and blood and urine metabolits
Date of disclosure of the study information 2023/04/01
Last modified on 2023/03/30 12:49:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study of the relationship between energy metabolism and blood and urine metabolits

Acronym

A study of the relationship between energy metabolism and blood and urine metabolits

Scientific Title

A study of the relationship between energy metabolism and blood and urine metabolits

Scientific Title:Acronym

A study of the relationship between energy metabolism and blood and urine metabolits

Region

Japan


Condition

Condition

Adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Identify blood and urine metabolites (acylcarnitines, TCA cycle intermediates, and other energy metabolism-related substances) that correlate with energy metabolism (energy expenditure, respiratory quotient, fat oxidation, carbohydrate oxidation and protein oxidation).

Basic objectives2

Others

Basic objectives -Others

Identify physiological parameter (Serum free fatty acids, serum triglycerides, hormone secretion, sleep EEG, body temperature, autonomic nervous system and heart rate) that correlate with energy metabolism (energy expenditure, respiratory quotient, fat oxidation, carbohydrate oxidation and protein oxidation).

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Energy metabolism and blood and urine metabolites

Key secondary outcomes

Serum free fatty acids, serum triglycerides, hormone secretion, sleep EEG, body temperature, autonomic nervous system and heart rate


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Normal diet

Interventions/Control_2

High fat diet

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

40 years-old >

Gender

Male and Female

Key inclusion criteria

Persons with no health problems
Persons with no sleep problems

Key exclusion criteria

Smokers
Shift Workers

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Katsuhiko
Middle name
Last name Yajima

Organization

Josai university

Division name

Faculty of Pharmacy

Zip code

350-0295

Address

1-1 Keyakidai, Sakado, Saitama

TEL

049-271-8015

Email

k-yajima@josai.ac.jp


Public contact

Name of contact person

1st name Katsuhiko
Middle name
Last name Yajima

Organization

Josai university

Division name

Faculty of Pharmacy

Zip code

350-0295

Address

1-1 Keyakidai, Sakado, Saitama

TEL

049-271-8015

Homepage URL


Email

k-yajima@josai.ac.jp


Sponsor or person

Institute

Josai university

Institute

Department

Personal name



Funding Source

Organization

Josai university

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Josai university

Address

1-1 Keyakidai, Sakado, Saitama

Tel

049-271-8015

Email

k-yajima@josai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2020 Year 09 Month 01 Day

Date of IRB

2020 Year 10 Month 09 Day

Anticipated trial start date

2022 Year 10 Month 10 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 03 Month 30 Day

Last modified on

2023 Year 03 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057778


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name